Australian Doctor 3rd Dec 2021 | Seite 43

®

PBS Information : This product is not listed on the National Immunisation Program ( NIP ) or the PBS .

Before prescribing please review the full Product Information available from sanofi pasteur or online via www . sanofi . com . au / en / our-products / PI-vaccines .
VIVAXIM ® Salmonella typhi Vi polysaccharide ( 25 mcg ) and inactivated hepatitis A virus antigen ( 160 antigen units ) vaccine . Indication : Simultaneous active immunisation against typhoid fever and hepatitis A virus infection in persons 16 years of age and over . Dosage and administration : The two vaccine components must only be mixed immediately prior to injection ( see full Product Information ), 1mL of the mixed vaccine as slow IM into the deltoid region . A booster of hepatitis A is required 6 to 36 months later to ensure long-term protection against hepatitis A . Revaccination against typhoid fever should be carried out every 3 years for those who remain at risk . Contraindications : History of severe allergic reaction to any component of the vaccine or after previous administration of VIVAXIM . Febrile or acute disease . Precautions : Appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic reaction . Hypersensitivity – may contain traces of neomycin , formaldehyde and polysorbate . Do not administer by intravascular injection . Subcutaneous administration may increase the risk of local adverse reaction . Individuals
with thrombocytopenia or bleeding disorder . Impaired immune system . Syncope . Pregnancy and lactation – category B2 . Adverse reactions : Local reactions : pain , erythema , oedema / induration , ecchymosis . Systemic reactions : headache , asthenia , malaise , pyrexia , nausea , diarrhoea , myalgia , arthralgia , dizziness , pruritus , rash . Very rarely : vomiting , abdominal pain , anaphylactic / anaphylactoid reactions including shock , serum sickness , vasovagal syncope , urticaria , transaminases increased . Date prepared : 05 March 2020 .
References : 1 . Vivaxim Approved Product Information . 2 . Overbosch D et al . J Travel Med 2005 ; 12 ( 6 ) 319 – 326 .
sanofi-aventis australia pty ltd . ABN 31 008 558 807 . Trading as SANOFI PASTEUR . Building D , 2 – 24 Talavera Road , Macquarie Park , NSW 2113 . Customer Service Enquiries 1800 829 468 . MAT-AU-2102518 . SSW . VIV-002761-00 November 2021 .

THEY ’ VE WAITED 2 YEARS TO TRAVEL

DON ’ T LET A BAD BEVVY RUIN IT

As the world reopens , the risk of contracting food and drink-borne diseases like hepatitis A and typhoid is still there .
One single shot completes a primary course , for up to three years of protection in adults . 1 , 2
®
Combined Purified Vi Polysaccharide Typhoid and Inactivated Hepatitis A Vaccine